A Year In Review
The ADC space is expanding faster than ever, with a 33% surge in new drugs and 23% in new clinical trials. Breakthroughs in bispecific ADCs and dual-payload technologies are shaping the future, while $64.3 billion in deals signal strong industry confidence.
Our Landscape Review delivers the key insights you need to stay competitive—from clinical trends to investment opportunities. Download now to make smarter, strategic decisions in this rapidly evolving field.
Download Now
Lead the future of ADC innovation!
The Beacon ADC 2024 Landscape Review is your definitive guide to the latest advancements in antibody-drug conjugates. Explore novel payloads, targets, and key clinical and commercial trends.
Report Contents
The Drug Landscape
A deep dive into the ADC assets added to Beacon in 2024, highlighting growth trends, emerging modalities, and key therapeutic targets.
The Trial Landscape
Analysis of the 660 new ADC trials, including phase distribution, success rates, and trial discontinuation insights.
The Commercial Market
A review of the 99 ADC deals in 2024, analyzing investment trends, partnerships, and market shifts.
The Future of ADCs
Emerging trends in ADC drug development, from novel payload mechanisms to expanding clinical applications.
Regulatory Announcements
Key ADC approvals and regulatory developments shaping the industry’s evolving compliance landscape.
Previous ADC Landscape Reviews
ADC 2024 H1 Landscape Review
An analysis of the ADC landscape in H1 of 2024
You May Also Be Interested In…
Learn More About ADC
- The Most Comprehensive Way to Search the ADC Drug Development Landscape: Unique search ontologies based on ADC drug and trial characteristics
- Market Leading Approach to ADC Preclinical & Clinical Data Curation: Manual curation of key ADC research and development data points by ADC research scientists
- Seamlessly Integrate Commercial & Scientific Data all in One Place: Search ADC company and deal data based on their pipeline and technologies.
- Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
What is Beacon?
Beacon is the essential intelligence platform for R&D decision-makers working in pharma and biotech, offering unique technology and drug datasets for complex therapeutics and disease areas.
Our market-defining proprietary ontologies, manual data curation, and accurate and comprehensive life science data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape.
This is why 24 of the top 25 pharmaceutical companies trust Beacon to power their critical pipeline, competitive, and commercial decisions.
We’d welcome the opportunity to show you how Beacon can transform your data strategy. Book your personalized demonstration today!
